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Abstract
Background: Macrosomia and hypertrophic cardiomyopathy are two features often associated in neonates of
diabetic mothers. We report the cases of three patients with severe macrosomia and critical hypertrophic
cardiomyopathy without severely unbalanced maternal diabetes. Only three patients with those two features and
no uncontrolled maternal diabetes have been previously reported.
Case presentation: The first patient was a 39-week-old girl, the second patient was a 39-week-old girl, and the
third patient was a 41-week-old boy. The two French girls and the French boy had severe macrosomia and
hypertrophic cardiomyopathy, leading to the death of the boy. The outcome of the two girls was favorable, with a
standardization of growth curves and ventricular hypertrophy. Their mothers presented with high body mass index
but no severe documented maternal diabetes; glycemic imbalance was only suspected on postnatal analyses. There
was no hydramnios during pregnancy and no other environmental factor, especially toxic exposure. Their parents
are from Mayotte, Guadeloupe, and Guinea-Conakry. The usual genetics causes, Beckwith–Wiedemann syndrome,
and chromosomal copy number variation, were also excluded.
Conclusions: This report suggests the implication of other factors in addition to glycemic disorders, including
genetic factors, in the occurrence of macrosomia and severe hypertrophic cardiomyopathy in neonates. These three
original observations indicate that gynecologists and neonatologists should pay attention to neonates from
mothers with a high body mass index and when maternal diabetes is not documented.
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Background
Newborn macrosomia is defined as neonate’s birthweight
over 4000 g and is usually attributed to maternal obesity,
gestational weight gain excess, and diabetes. Macrosomia
may also be part of a genetic disorder, such as Beck-
with–Wiedemann syndrome (BWS), Online Mendelian
Inheritance in Man (OMIM) database number 130650;
Simpson–Golabi–Behmel syndrome, OMIM 312870; or
Perlman syndrome, OMIM 267000. Cardiomyopathy is
not a common feature in those three pathologies.
Hypertrophic cardiomyopathy (HCM) can be sporadic or
familial. In familial cases, all modes of inheritance are de-
scribed, but an autosomal dominant manner is the most
common. HCM is also related to gestational diabetes melli-
tus (GDM), in particular when diabetes is unbalanced in
late gestation [1]. HCM was identified as the most common
cardiac malformation in fetuses of diabetic mothers, but se-
vere HCM, defined as having an end-diastolic interventric-
ular septal thickness (IVSd) Z-score >2, is rarely described.
There are only a few reports in the literature of patients
with macrosomia and severe HCM, for which uncon-
trolled GDM was not confirmed [2–4]. Here we report on
three cases neonates presenting with severe macrosomia
and HCM, without extreme maternal diabetes.
Cases presentation
Patient 1
The first patient was a 39-week-old baby girl born by
cesarean section because of macrosomia. She was the first-
born of unrelated and unaffected parents from Mayotte,
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with no remarkable family history. Pregnancy was unevent-
ful with normal ultrasounds, no hydramnios, and no toxic
exposure. Her mother’s height and weight were 176 cm and
115 kg, giving a body mass index (BMI) of 36.5 kg/m2. No
oral glucose tolerance test (OGTT) was performed during
pregnancy, but 2 days after delivery her mother’s OGTT was
in the normal range. Her mother’s postnatal glycated
hemoglobin (HbA1C) value was 7.1 % (normal <6 %), which
means that her glycemia levels were probably slightly elevated
during pregnancy (see details in Additional file 1: Table S1).
Patient 1’s birth weight (BW) was 5660 g (+4 standard
deviation (SD)), birth length (BL) 57 cm (+3 SD), and
her birth occipitofrontal circumference (OFC) 37.5 cm
(+3 SD). Her Apgar score was 5 at 1 minute and 7 at 5
minutes due to cardiogenic shock with severe pulmonary
arterial hypertension. A cardiac ultrasound showed a se-
vere biventricular non-obstructive HCM, with an IVSd
at 12 mm (+5.2 Z-score cardiac parameter Dubois) and
virtual cavity in her left ventricle (Fig. 1a). Her clinical
condition required an extracorporeal membrane oxygen-
ation (ECMO) in emergency for 5 days. She was intu-
bated for 11 days, with 2 days of high frequency
oscillation (HFO). Metabolic investigations and cerebral
magnetic resonance imaging (MRI) were normal. HCM
decreased in 2 weeks and macrosomia disappeared
(Fig. 2a). At 36 months, a cardiac ultrasound showed a
residual hypertrophy of her left ventricle at 3 mm, with
an aspect of thick and hyperechogenic myocardium. Her
weight was 15.5 kg (+1.5 SD), her length was 94.5 cm
(+0.5 SD), and her OFC was 46.5 cm (–1.5 SD; Fig. 2a).
Her psychomotor development was normal.
Patient 1’s mother developed documented slight GDM
during her following pregnancy, which was only treated
with diet; her newborn did not have macrosomia or HCM.
Patient 2
The second patient was a 39-week-old baby girl born by
cesarean section because of fetal arrhythmia and
A B
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Fig. 1 Echocardiography of the three patients. a Patient 1. Severe biventricular non-obstructive hypertrophic cardiomyopathy (interventricular septal
thickness 12 mm, +5.2 Z-score) and virtual cavity in the left ventricle. b Patient 2. Hypertrophic cardiomyopathy predominant left (interventricular septal
thickness 8 mm, +3.2 Z-score). c Patient 3. Severe hypertrophic cardiomyopathy (interventricular septal thickness 7 mm, +2.8 Z-score), with virtual cavity
in the left ventricle and cardiac function alteration
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macrosomia. She was the fourth-born of unrelated
and unaffected parents from Guadeloupe. Her family
history was unremarkable. Her mother’s and father’s
weight and height were 80 kg and 176 cm (BMI 25.5
kg/m2), and 130 kg and 190 cm. The BWs of her
mother, father, and her siblings were respectively
3000 g, 4000 g, 4400 g, 4900 g and 4700 g. Preg-
nancy was uneventful with normal ultrasounds until
38 weeks; there was no hydramnios and no toxic ex-
posure. Her mother’s OGTT at 22 weeks was normal
and HbA1C was also in the normal range at 5.5 %
10 days after delivery (see details in Additional file 1:
Table S1).
The BW of Patient 2 was 6850 g (+6.5 SD), BL was 59
cm (+4 SD), and birth OFC was 38 cm (+3 SD). She re-
quired immediately oxygen for transient neonatal re-
spiratory distress; a cardiac ultrasound revealed HCM
(IVSd 8 mm, +3.2 Z-score cardiac parameter Dubois;
Fig. 1b). Molecular analysis of BWS was negative, and
deoxyribonucleic acid (DNA)-microarray was normal.
At 21 months, her weight was 14.5 kg (+3 SD), her
length was 87 cm (+2 SD), and her OFC was 48 cm (+1
SD; Fig. 2b). Her psychomotor development was normal
and a cardiac ultrasound showed mild HCM.
Patient 3
The third patient was a 41-week-old baby boy born by
cesarean section because of fetal arrhythmia and decreased
fetal movements. He was the first-born of unrelated and
unaffected parents from Guinea-Conakry. His family his-
tory was uneventful. His mother’s height and weight were
173 cm and 80 kg, giving a BMI of 27 kg/m2. Antenatal ul-
trasounds were normal, without hydramnios, and no drug
or toxic exposition was documented. There was no suspi-
cion of maternal diabetes, so OGTT was not performed
during pregnancy; his mother’s OGTT was normal 3 days
after delivery (see details in Additional file 1: Table S1).
His BW was 5000 g (+5.5 SD), BL 54 cm (+3 SD), and
birth OFC 37 cm (+2 SD). He was born in a state of
apparent death and was directly intubated for artificial
ventilation with HFO because of refractory hypoxemia. He
developed pulmonary hypertension at day 5 and echocar-
diography revealed severe HCM (IVSd 7 mm, +2.8
Z-score cardiac parameters Dubois; Fig. 1c). Several epi-
sodes of hypoglycemia were documented and a cerebral
MRI revealed massive ischemic and hemorrhagic lesions.
Death occurred at the fifth day of life. An autopsy was not
done because of parental refusal. BWS molecular analysis
was normal.
A B
Fig. 2 Growth curves of patients 1 and 2. a Patient 1. b Patient 2. Note the standardization of the measurements
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Discussion
HCM is a well-known complication in babies of diabetic
mothers [5–8], and is attributed to a compensatory in-
crease in fetal insulin secretion. While HCM in babies of
diabetic mothers is usually mild and reversible, it is
rarely severe leading to fetal or neonatal death. Only five
patients with severe neonatal HCM were reported previ-
ously in association with GDM [2, 3, 9–11]. Other stud-
ies showed that glucose and insulin levels were not so
predictive of fetal macrosomia [12, 13].
Sardesai et al. reported the case of a fetus with fatal
HCM and macrosomia. The mother had a well-controlled
GDM under insulin therapy [2]. Moreover, Mehta and
Hussain described another patient with transient hyperin-
sulinism associated with macrosomia, severe obstructive
HCM, hepatomegaly, and nephromegaly in a mother with
mild GDM requiring no treatment [3]. Maternal postnatal
OGTT was negative, and follow-up showed an improve-
ment of the HCM with a mild residual left ventricular
hypertrophy. In those two last case reports, it seems
difficult to attribute the severe features observed only to a
benign GDM.
Furthermore, Godfried and coworkers reported the
case of a patient with severe HCM, macrosomia (BW
5290 g), and hepatomegaly born to a mother with
human immunodeficiency virus (HIV) infection [4].
GDM and other metabolic disorders were excluded, and
a relationship between the neonatal abnormalities and
antiretroviral treatment was suspected. Other toxic
causes have not been reported in the literature and there
was no history of toxic exposure for our three patients.
Maternal diabetes was excluded in the mother of
Patient 2. OGTT of the mothers of Patients 1 and 3
were not performed during pregnancy but postnatal ana-
lyses do not indicate severe glycemia disequilibrium.
Even if we consider mild GDM in those two cases, this
cannot explain completely, in our opinion, the severity
of the children’s phenotype.
The three major genetic overgrowth syndromes in-
cluding BWS, Simpson–Golabi–Behmel syndrome, and
Perlman syndrome, do not usually present with cardio-
myopathy. Cardiomyopathy has been rarely reported in
BWS [14, 15], but molecular analysis ruled out this
hypothesis in Patients 2 and 3.
To date, more than 13 genes have been identified for
isolated HCM. Most of them are inherited in an auto-
somal dominant pattern. In the present report we did
not consider monogenic forms of HCM because of
macrosomia, the spontaneously favorable evolution, and
the absence of family history.
Conclusions
We reported the case of three patients with macrosomia
and severe HCM at birth. We hypothesize that other
additional factors to maternal diabetes, such as genetic
and/or metabolic factors, might be involved in the deter-
minism of this phenotype. We propose that gynecologists
should perform OGTT during pregnancy in cases of high
BMI, even if there is no familial history of GDM or hy-
dramnios. We propose also that neonatologists and
pediatric cardiologists pay special attention to neonates
presenting with macrosomia, even if no GDM has been
documented, and pay attention to other potential factors.
Additional file
Additional file 1: Table S1. Mothers’ oral glucose tolerance test (OGTT)
of patients 1, 2, and 3. (XLS 20 kb)
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